Clinical Trials Directory

Trials / Completed

CompletedNCT02392767

Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function

Effect of a Dietary Supplement on Endothelial Function in Volunteers With Light to Moderate Hypertension - a Randomised, Double-blind, Placebo Controlled Cross-over Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Dr. Loges & Co. GmbH · Industry
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

The effect of a combination product (Verum ) with L-arginine, Pycnogenol, vitamin K2, R-(+)-alpha-lipoic acid and vitamins B6, B12 and folic acid is investigated in a double blind placebo-controlled cross-over study. Volunteers with hypertension and hyperhomocysteinemia are randomly assigned to the dietary supplement or placebo.

Detailed description

25 patients were included in the trial. Intervention period was 4 weeks with 2 months wash out phase. The screening visit of all volunteers before study start included volunteer information, signature of informed consent, anamnesis, medical history, ECG and blood routine analysis. Efficacy parameters were measured at visit 1, 2, 3, and 4. Endothelial function and postprandial endothelial Reaction was tested using EndoPAT (validated diagnosis tool). Blood pressure was measured by volunteers over a period of 7 days before each visit. As additional parameters homocysteine and ADMA (assymmetric dimethyl arginine) were determed. For safety evaluation AEs (Adverse Events), CC (compliance control), tolerability, blood routine parameters and vital signs were assessed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVerum2400 mg L-arginine, 80 mg Pycnogenol, 45µg vitamine K2, 10 mg R (+) alpha lipoic acid, 8 mg vitamine B6, 500 µg vitamine B12, and 600 mg folic acid.
DIETARY_SUPPLEMENTPlacebocorn starch

Timeline

Start date
2014-10-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2015-03-19
Last updated
2016-05-02
Results posted
2016-05-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02392767. Inclusion in this directory is not an endorsement.